Eli Lilly and Company · LLY · Next earnings

Eli Lilly and Company reports Thursday, Oct 29, 2026

LLY reports before market open with consensus EPS at $9.85 and revenue at $22.19B. Last quarter: Eli Lilly Beats on Revenue and EPS as Foundayo Launch Ignites 56% Growth

Reports Before market open39 days awayDate estimated Healthcare

What the street expects

Consensus for the coming report
Consensus EPS $9.85 Calendar consensus
Consensus revenue $22.19B Calendar consensus
Report date Oct 29, 2026 Thursday, date estimated
Session Before market open 39 days away

Where LLY left off: FY2026 Q1

Full report

Eli Lilly Beats on Revenue and EPS as Foundayo Launch Ignites 56% Growth

EPS surprise +22.7% Reported $8.55 vs $6.97
Revenue surprise +11.1% Reported $19.80B vs $17.82B
Stock move +9.8% Event window
Subsequent drift +18.2% Up to 20 sessions

Full-year 2026 revenue guidance raised from $80-$83B to $82-$85B. Non-GAAP EPS guidance raised from $33.50-$35 to $35.50-$37. Both the revenue floor and ceiling moved up by approximately $2B, and the EPS range shifted higher by roughly $2 at both ends, reflecting Foundayo contribution and sustained incretin volume growth.

What to watch on the call

Carried forward from the last transcript

Risks management flagged

  • U.S. pricing pressure from Medicare, Medicaid, and Part D contracting affecting margins
  • Loss of Medicaid access in some states impacting prescription growth
  • Regulatory uncertainty for new indications and international approvals of Foundayo
  • Potential generic semaglutide competition affecting market dynamics
  • Reliance on volume expansion to offset declining realized prices

Questions analysts left open

  • Impact of pricing scenarios on margins and operating leverage
  • Sustainability of international Mounjaro growth amid generic semaglutide entry
  • Timeline and revenue contribution of Foundayo to 2026 guidance
  • Effectiveness of Employer Connect and Medicare bridge programs in driving patient uptake
  • DTC channel strategy and its influence on overall sales mix

Ask FN2 about LLY next report

Transcript, numbers and history already loaded
What should I watch for in LLY's next earnings report?How did LLY guide last quarter, and is consensus above or below that?Give me the bull and bear case going into LLY earnings.

Free account. Your question opens in FN2 with this report's transcript and numbers attached.

Get the LLY recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Recent LLY quarters

All LLY earnings
+9.8%FY2026 Q1

Sources

  1. FN2 corporate events calendar, resolved from the earnings calendar feed
  2. FN2 earnings calendar analyst consensus
  3. Earnings call transcript analysis, FY2026 Q1

Methodology

The report date comes from FN2's resolved corporate-events calendar and is marked estimated until the company confirms it. Consensus figures are the calendar's latest analyst estimates for the fiscal period and are not an FN2 forecast.

Risks and open questions are carried forward verbatim from FN2's structured analysis of the previous earnings call. Missing values stay missing and are never estimated.

By FN2 Research · Updated . For educational purposes only; not investment advice.